These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transplantation Outcome in Recipients Engrafted With Organs Recovered From the First French Deceased Donor With a SARS-COV-2 Vaccine-induced Thrombotic Thrombocytopenia. Jamme M; Elalamy I; d'Izarny Gargas T; Pettenati C; Desire E; Tissot A; Rabant M; Lefebvre M; Soorojebally Y; Vourc'h M; Conti F; Ferlicot S; Delahousse M; Sartorius-Brodin A; Hertig A Transplantation; 2021 Aug; 105(8):e84-e86. PubMed ID: 34115658 [No Abstract] [Full Text] [Related]
4. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2. Book BAJ; Schmidt B; Foerster AMH JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612 [No Abstract] [Full Text] [Related]
5. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095 [No Abstract] [Full Text] [Related]
6. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates. Behr MA; Divangahi M; Schurr E J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239 [TBL] [Abstract][Full Text] [Related]
7. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination. Ralph Edwards I; Lindquist M Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947 [No Abstract] [Full Text] [Related]
8. In brief: Johnson & Johnson COVID-19 vaccine suspended. Med Lett Drugs Ther; 2021 May; 63(1623):e1. PubMed ID: 33976102 [No Abstract] [Full Text] [Related]
9. Africa's need for more COVID-19 clinical trials. Makoni M Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137 [No Abstract] [Full Text] [Related]
10. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination. Hammerschmidt SI; Bosnjak B; Bernhardt G; Friedrichsen M; Ravens I; Dopfer-Jablonka A; Hoffmann M; Pöhlmann S; Behrens GMN; Förster R Cell Mol Immunol; 2021 Oct; 18(10):2455-2456. PubMed ID: 34426672 [No Abstract] [Full Text] [Related]
11. Status of vaccine development for COVID-19. Mendes A Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511 [No Abstract] [Full Text] [Related]
13. [COVID-19 vaccines increase the risk of anaphylaxis]. Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103 [No Abstract] [Full Text] [Related]
14. A COVID-19 vaccine-dare to dream. Phillis A Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccines approved in the European Union: current evidence and perspectives. Bellino S Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126 [No Abstract] [Full Text] [Related]
19. [COVID-19 vaccines and cancer patients: State of the art and guidelines summary]. Kharmoum S; El M'Rabet FZ Bull Cancer; 2021 May; 108(5):553-555. PubMed ID: 33902920 [No Abstract] [Full Text] [Related]
20. Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy. Scoccianti S; Delli Paoli C; Grilli Leonulli B; Paoletti L; Alpi P; Caini S; Barca R; Fondelli S; Russo S; Perna M; Pino MS; Martella F; Furlan F; Bassetti A; Fioretto L Lancet Oncol; 2021 Sep; 22(9):1212-1214. PubMed ID: 34388385 [No Abstract] [Full Text] [Related] [Next] [New Search]